Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

ENSCC European Network on the Supramolecular Chemistry of Carbohydrates

Coordinator
Universita Degli Studi Di Firenze, Italy
Runs
1 March 2024 to 29 February 2028
Status
Running
EU funding
€2.7m
Total cost
—
Partners
14 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101119492

What the project is doing

In the project's own words, from its summary on CORDIS.

Carbohydrates are nature’s most abundant and versatile molecules and are involved in several diseases (e.g. diabetes, infection, andcancer metastasis) and other regular processes (e.g. fertilization, immune surveillance and inflammatory responses). Understanding,monitoring and intervening in these processes could be exploited in medicinal therapies, glycobiology, and biomedical research ingeneral. Such applications are predicated on the availability of carbohydrate binding molecules (CBMs) that can selectively andsupramolecularly (noncovalently) bind a plethora of carbohydrate molecules ranging from simple monosaccharides to complexoligosaccharides and glycoconjugates.

Technologies that can be developed based on CBMs include: the separation and isolation ofcarbohydrate containing molecules; making carbohydrate sensing and detection devices; enabling selective chemistry on(unprotected) carbohydrates; and a range of bio-functional applications. While the expertise to design, synthesize, study and exploit CBMs is mostly European, the research groups active in this emergingfield work independent from each other.

With this doctoral network grant, we aim to unite this expertise in the ‘European Network forthe Supramolecular Chemistry of Carbohydrates’ (ENSCC). With most of the world’s leading minds on the topic and three companiesthat are spearheading technologies in the field, our ENSCC will be a European powerhouse that will lead the academic field globallyfor years to come. This will be achieved by sharing expertise, key-infrastructure, molecular building blocks, and –most importantly– bytogether training the ten PhDs that this doctoral network grant will fund.

This training by a unique network of world-leaders, expertsin the field and companies with an interest in CBMs will perfectly position our PhD students to further develop the field by continuingtheir career in academia and/or industry.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di FirenzeFlorenceItalyCoordinator
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Kobenhavns UniversitetKobenhavnDenmarkAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Asociacion Centro De Investigacion Cooperativa En Biociencias Cic BioguneDerio VizcayaSpainParticipant
Atlas Molecular Pharma SLDerioSpainParticipant
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Universite De BordeauxBordeauxFranceAssociatedpartner
Giotto Biotech SRLFirenzeItalyParticipant
Technische Universiteit EindhovenEindhovenNetherlandsAssociatedpartner
Universiteit UtrechtUtrechtNetherlandsParticipant
University of BristolBristolUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI